The FDA has approved Starjemza (ustekinumab-hmny), a biosimilar to Stelara (ustekinumab), for the treatment of various chronic inflammatory diseases.

Physical activity levels have a significant association with a reduced incidence of restrictive spirometry patterns (RSP).

The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.

More than one-third of patients with SSc screened positive for self-reported depression, with GI involvement identified as the most significant predictor.

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

Research findings increasingly indicate close associations between autoimmune thyroid disease and rheumatic disease.

The global age-standardized incidence and prevalence rates of RA increased from 1990 to 2021 while mortality rates declined.

Metformin was associated with significantly reduced knee pain among patients with overweight/obesity and knee osteoarthritis.

Supervised combined exercises and neuromuscular training may be the most effective NPIs for improving disease activity, function, and spinal mobility in axSpA.

Dry eye disease metrics, such as NIBUT and MG dropout, may serve as predictive biomarkers for possible thyroid disorders.

Neuraxial anesthesia is associated with significantly reduced odds of several major postoperative complications in patients undergoing hip fracture procedures, according to resear ...